Similar articles for PMID: 16334165

Year	Number of Results
1988	1
1995	1
1996	1
1997	1
1998	1
1999	2
2000	5
2001	2
2002	3
2003	5
2004	11
2005	10
2006	10
2007	3
2008	2
2009	2
2010	3
2011	3
2013	1
2017	1
2024	0

1

Docetaxel administered every two weeks as second-line chemotherapy for advanced non-small cell lung cancer: a phase II study.

De Petris L, Migliorino MR, Ceribelli A, Martelli O, Di Molfetta M, Mancuso A, De Santis S, Di Salvia R, De Marinis F. De Petris L, et al. Anticancer Res. 2005 Nov-Dec;25(6C):4713-7. Anticancer Res. 2005. PMID: 16334165 Free article. Clinical Trial.

2

Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.

Schuette W, Nagel S, Blankenburg T, Lautenschlaeger C, Hans K, Schmidt EW, Dittrich I, Schweisfurth H, von Weikersthal LF, Raghavachar A, Reissig A, Serke M. Schuette W, et al. J Clin Oncol. 2005 Nov 20;23(33):8389-95. doi: 10.1200/JCO.2005.02.3739. J Clin Oncol. 2005. PMID: 16293869 Clinical Trial.

3

Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancer.

Lai CL, Tsai CM, Chiu CH, Wang GS, Su WJ, Chen YM, Perng RP. Lai CL, et al. Jpn J Clin Oncol. 2005 Dec;35(12):700-6. doi: 10.1093/jjco/hyi191. Epub 2005 Nov 22. Jpn J Clin Oncol. 2005. PMID: 16303792 Clinical Trial.

4

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, Lim HL, Desch C, Szondy K, Gervais R, Shaharyar, Manegold C, Paul S, Paoletti P, Einhorn L, Bunn PA Jr. Hanna N, et al. J Clin Oncol. 2004 May 1;22(9):1589-97. doi: 10.1200/JCO.2004.08.163. J Clin Oncol. 2004. PMID: 15117980 Corrected and republished. Clinical Trial.

5

A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy.

Chen YM, Shih JF, Perng RP, Tsai CM, Whang-Peng J. Chen YM, et al. Chest. 2006 Apr;129(4):1031-8. doi: 10.1378/chest.129.4.1031. Chest. 2006. PMID: 16608954 Clinical Trial.

6

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.

Kwon JH, Kim JH, Lee JA, Shin HC, Kim HJ, Song HH, Jung JY, Kim HY, Choi DR, Kim HS, Park YI, Zang DY. Kwon JH, et al. Cancer Chemother Pharmacol. 2010 Oct;66(5):889-97. doi: 10.1007/s00280-009-1235-y. Epub 2010 Jan 21. Cancer Chemother Pharmacol. 2010. PMID: 20091311 Clinical Trial.

7

Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.

Feliu J, Martín G, Castro J, Sundlov A, Rodriguez-Jaráiz A, Casado E, Lomas M, Madroñal C, Galán A, Belda C, Gonzalez-Barón M. Feliu J, et al. Cancer Chemother Pharmacol. 2006 Oct;58(4):527-31. doi: 10.1007/s00280-006-0198-5. Epub 2006 Mar 23. Cancer Chemother Pharmacol. 2006. PMID: 16555090 Clinical Trial.

8

Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: phase II trial.

Serke M, Schoenfeld N, Loddenkemper R. Serke M, et al. Anticancer Res. 2004 Mar-Apr;24(2C):1211-6. Anticancer Res. 2004. PMID: 15154649 Free article. Clinical Trial.

9

Second-line chemotherapy with a modified schedule of docetaxel in elderly patients with advanced-stage non-small-cell lung cancer.

Tibaldi C, Bernardini I, Chella A, Russo F, Vasile E, Malventi M, Falcone A. Tibaldi C, et al. Clin Lung Cancer. 2006 May;7(6):401-5. doi: 10.3816/CLC.2006.n.024. Clin Lung Cancer. 2006. PMID: 16800966 Clinical Trial.

10

Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).

Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, Shinkai T, Sawa T, Goto I, Semba H, Seto T, Ando M, Satoh T, Yoshimura N, Negoro S, Fukuoka M. Kudoh S, et al. J Clin Oncol. 2006 Aug 1;24(22):3657-63. doi: 10.1200/JCO.2006.06.1044. J Clin Oncol. 2006. PMID: 16877734 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

67 results

Results by year